2.3000
+0.2500
+(12.20%)
At close: April 9 at 4:00:03 PM EDT
2.2400
-0.06
(-2.61%)
Pre-Market: 8:00:01 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 5 | 7 |
| Avg. Estimate | -0.27 | -0.29 | -1.2 | -1.34 |
| Low Estimate | -0.29 | -0.31 | -1.24 | -1.56 |
| High Estimate | -0.26 | -0.28 | -1.12 | -1.13 |
| Year Ago EPS | -0.3 | -0.31 | -1.12 | -1.2 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 9 | 7 |
| Avg. Estimate | -- | -- | -- | 1.37M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 9.6M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.35 | -0.34 | -0.32 | -0.3 |
| EPS Actual | -0.3 | -0.31 | -0.28 | -0.24 |
| Difference | 0.05 | 0.03 | 0.04 | 0.06 |
| Surprise % | 13.22% | 8.74% | 12.91% | 20.05% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.27 | -0.29 | -1.2 | -1.34 |
| 7 Days Ago | -0.32 | -0.33 | -1.33 | -1.4 |
| 30 Days Ago | -0.32 | -0.33 | -1.32 | -1.39 |
| 60 Days Ago | -0.32 | -0.33 | -1.32 | -1.39 |
| 90 Days Ago | -0.32 | -0.33 | -1.32 | -1.39 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 4 | 2 |
| Up Last 30 Days | -- | -- | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TERN | 9.25% | 5.15% | -6.80% | -11.81% |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Initiated | William Blair: Market Perform | 2/28/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 12/4/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 12/4/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 12/4/2024 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 11/13/2024 |
| Initiated | Oppenheimer: Outperform | 10/31/2024 |
Related Tickers
ALT Altimmune, Inc.
4.2300
+15.26%
GPCR Structure Therapeutics Inc.
15.27
+7.92%
SRRK Scholar Rock Holding Corporation
27.06
+10.58%
MDGL Madrigal Pharmaceuticals, Inc.
313.95
+3.69%
ETNB 89bio, Inc.
5.54
+14.70%
SGMT Sagimet Biosciences Inc.
2.2700
+19.47%
VKTX Viking Therapeutics, Inc.
23.10
+15.62%
SNDX Syndax Pharmaceuticals, Inc.
11.52
+9.09%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.5821
+9.83%
IMUX Immunic, Inc.
0.9246
+3.31%